These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 18270879

  • 1. R+ pramipexole as a mitochondrially focused neuroprotectant: initial early phase studies in ALS.
    Wang H, Larriviere KS, Keller KE, Ware KA, Burns TM, Conaway MA, Lacomis D, Pattee GL, Phillips LH, Solenski NJ, Zivkovic SA, Bennett JP.
    Amyotroph Lateral Scler; 2008 Feb; 9(1):50-8. PubMed ID: 18270879
    [Abstract] [Full Text] [Related]

  • 2. Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.
    Ferrante KL, Shefner J, Zhang H, Betensky R, O'Brien M, Yu H, Fantasia M, Taft J, Beal MF, Traynor B, Newhall K, Donofrio P, Caress J, Ashburn C, Freiberg B, O'Neill C, Paladenech C, Walker T, Pestronk A, Abrams B, Florence J, Renna R, Schierbecker J, Malkus B, Cudkowicz M.
    Neurology; 2005 Dec 13; 65(11):1834-6. PubMed ID: 16344537
    [Abstract] [Full Text] [Related]

  • 3. Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.
    Bennett J, Burns J, Welch P, Bothwell R.
    J Alzheimers Dis; 2016 Dec 13; 49(4):1179-87. PubMed ID: 26682692
    [Abstract] [Full Text] [Related]

  • 4. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study).
    Yoshino H, Kimura A.
    Amyotroph Lateral Scler; 2006 Dec 13; 7(4):241-5. PubMed ID: 17127563
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.
    Cheah BC, Kiernan MC.
    IDrugs; 2010 Dec 13; 13(12):911-20. PubMed ID: 21154151
    [Abstract] [Full Text] [Related]

  • 9. Erythropoietin in amyotrophic lateral sclerosis: a pilot, randomized, double-blind, placebo-controlled study of safety and tolerability.
    Lauria G, Campanella A, Filippini G, Martini A, Penza P, Maggi L, Antozzi C, Ciano C, Beretta P, Caldiroli D, Ghelma F, Ferrara G, Ghezzi P, Mantegazza R.
    Amyotroph Lateral Scler; 2009 Dec 13; 10(5-6):410-5. PubMed ID: 19922132
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Correlates of quality of life in ALS: Lessons from the minocycline study.
    Lou JS, Moore D, Gordon PH, Miller R.
    Amyotroph Lateral Scler; 2010 Dec 13; 11(1-2):116-21. PubMed ID: 19551536
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: subgroup analysis of demographic and clinical characteristics.
    Rudnicki SA, Berry JD, Ingersoll E, Archibald D, Cudkowicz ME, Kerr DA, Dong Y.
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Jan 13; 14(1):44-51. PubMed ID: 22985432
    [Abstract] [Full Text] [Related]

  • 16. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study.
    Prabhakar S, Marwaha N, Lal V, Sharma RR, Rajan R, Khandelwal N.
    Neurol India; 2012 Jan 13; 60(5):465-9. PubMed ID: 23135021
    [Abstract] [Full Text] [Related]

  • 17. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort InvestigatorsDepartment of Neurology, University of Rochester, 1351 Mt Hope Ave, Ste 220, Rochester, NY 14620, USA. kevin.biglan@ctcc.rochester.edu.
    Arch Neurol; 2009 May 13; 66(5):563-70. PubMed ID: 19433655
    [Abstract] [Full Text] [Related]

  • 18. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Scand J Clin Lab Invest; 2007 May 13; 67(3):264-9. PubMed ID: 17454840
    [Abstract] [Full Text] [Related]

  • 19. Motor cortex stimulation for ALS: a double blind placebo-controlled study.
    Di Lazzaro V, Pilato F, Profice P, Ranieri F, Musumeci G, Florio L, Beghi E, Frisullo G, Capone F, Sabatelli M, Tonali PA, Dileone M.
    Neurosci Lett; 2009 Oct 16; 464(1):18-21. PubMed ID: 19682544
    [Abstract] [Full Text] [Related]

  • 20. Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals.
    Galasko DR, Graff-Radford N, May S, Hendrix S, Cottrell BA, Sagi SA, Mather G, Laughlin M, Zavitz KH, Swabb E, Golde TE, Murphy MP, Koo EH.
    Alzheimer Dis Assoc Disord; 2007 Oct 16; 21(4):292-9. PubMed ID: 18090435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.